Skip to main content
. 2005 Apr;25(8):3220–3231. doi: 10.1128/MCB.25.8.3220-3231.2005

TABLE 2.

ChIP PCR primers used in this study

Primer Sequence
IgκEi
    Forward 5′ CAG AGG GGA CTT TCC GAG AGG CC 3′
    Reverse 5′ ACC CTG GTC TAA TGG TTT GTA AC 3′
IgκE3′
    Forward 5′ ATA GCA ACT GTC ATA GCT ACC GT 3′
    Reverse 5′ GCA GGT GTA TGA GGC TTT GGA AA 3′
IgκEd
    Forward 5′ GGG ACA GAT CAC CAT TTC GTT AA 3′
    Reverse 5′ CTT CAG GCC AGC TGG GCA GTG AG 3′
Negative control-1
    Forward 5′ CTA ATA GTC CCA TGC TCT CC 3′
    Reverse 5′ TCC TTC CTT TGG TGG CTT C 3′
Negative control-2
    Forward 5′ GGG TAG TTT TCC CAA CGA ACA GT 3′
    Reverse 5′ GGA TGG TTT TCT TAA AGA GTG TGA G 3′
Vκ19-17 promoter
    Forward 5′ GAT GAC TCC TTT GCA TAG ATC CC 3′
    Reverse 5′ TCA CCA GAC AAC CAG AGA AAC AC 3′
Vκ4-58 promoter
    Forward 5′ TGA CAT CTG TGT TTG ACA ATT GG 3′
    Reverse 5′ CTC CCA CAA TAA AGA ATC AAG AAT G 3′
HHS Vulnerability Disclosure